ABOUT BONE HEALTH TECHNOLOGIES (BHT)

OSTEOPENIA AND OSTEOPOROSIS TREATMENT INNOVATION

A new way of thinking about an age-old problem

At Bone Health Technologies, we develop breakthrough solutions to help people defend against osteoporosis and osteopenia. Our mission is simple: to empower people to lead longer, stronger, and more active lives by safeguarding bone density from the effects of menopause, aging, cancer, and other degenerative causes of bone loss.

Our first holistic bone health solution, Osteoboost, is FDA-cleared to treat osteopenia in postemenopausal women and first devices are expected to ship soon.

This journey is just beginning, and we’re happy you’re here.

Our customers

FOR PATIENTS AND CAREGIVERS

We offer innovative, holistic solutions to slow the loss of bone density and strength, and keep you active and healthy longer.

FOR MEDICAL PROFESSIONALS

We provide a safe and convenient non-drug therapy, plus an actionable platform for tracking patient progress in tandem with your routine DEXA scanning.

Who prescribes Osteoboost? Primary care and internal medicine doctors, endocrinologists, OB/GYN professionals, rheumatologists, nephrologists, gerontologists, oncologists, physical therapists, and more.

FOR HEALTH SYSTEMS

We deliver an affordable way to significantly reduce the cost of bone fractures while affording patients a higher quality of life.

Leadership

Laura Yecies

Chief Executive Officer, President

Serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). Led successful brands at Check Point, Netscape, Yahoo. MBA from Harvard, MSFS Georgetown.

Michael Jaasma

Co-founder, Chief Scientific Officer

Co-founder of BHT, 20 years as a technical lead in medical device development. PhD in orthopedic biomechanics from UC Berkeley. Former Reviewer and Branch Chief at the FDA in CDRH.

Pamela Peeke, MD

Chief Medical Officer

Expert in women’s health, menopause, and longevity, member of the National Menopause Foundation Medical Advisory Board and a Trustee on the American College of Sports Medicine Board.

Derek Hillstrom

VP Engineering

20 years of medical device development and manufacturing at St Jude Medical, Autonomic Technologies and Niveus Medical. University of Missouri, Aerospace, Aeronautical and Astronautical Engineering

Gabriel Griego

Marketing

Seasoned sales, marketing, and revenue/commercialization leader. Track-record of successfully designing and executing go-to-market for consumer/medical products. Led marketing for PowerBar, Game Ready, and AlterG.

Daniel Beeler

Vice President, Operations


Operational leader at scale, highly experienced with technical, regulatory, clinical, and commercial medical device development. Former CEO at Cardiospire and CTO at SyncThink and Metascrape.

Priya Patel

Chief Product Officer


Entrepreneur and product leader. Founder and CEO of Wellen (acq. by BHT), a science-based osteoporosis exercise platform. Former Head of Product at Sesame. A.B. from Harvard, J.D. from Columbia.

Dave McGurl

Regulatory


Director of Regulatory Affairs at MCRA and expert in orthopedics and medical devices. worked for 7 years at the FDA in the premarket orthopedic devices as acting branch chief and senior premarket lead reviewer.

Board of Directors

Laura Yecies

President and Chief Executive Officer at Bone Health Technologies

Shane Mangrum, MD

Co-founder and co-inventor, Bone Health Technologies, PM&R physician at Polaris Spine

Eric Meyer

Independent Board Member and strategic advisor at Bone Health Technologies

Jeani Delagardelle

Co-founder and former Managing Director of New Leaf Venture Partners

photo of Ella Seitz from Esplanade Ventures

Ella Seitz

Partner at Esplanade Ventures. Leader in driving growth, digitization and new business models in healthcare.

Sam Goldberger, MD

Co-Founder and Managing Partner of Ambit Health Ventures. Ophthalmologist and ophthalmic surgeon.

Photograph of Eran Steinburg

Eran Steinberg

Serial Entrepreneur with 5 successful exits.
Early stage investor and board member, >300 granted patents,
MSc. Imaging Science, MS Regulatory Science

John Osborne

Managing Partner, Good Growth Capital. Co-founded and Director of The Harbor Entrepreneur Center. (Board observer)

Our investors

Special thanks to our incredible investors who believe in Osteoboost and want to make the world a better, stronger, and healthier place for everyone.

A list of investors in Osteoboost, including Terumo, Esplanade, IT Farm, Ambit Health Ventures, Band of Angels, Portfolia, Good Growth Capital, and Astia.

Recent announcements

Osteoboost Pre-Orders Open: Breakthrough Medical Device to Treat Low Bone Density Begins Shipping Soon

First-of-its-kind FDA-cleared precision vibration therapy wearable device to treat millions at risk of fracture from osteopenia REDWOOD CITY, CALIF – December 4, 2024 – Bone Health Technologies (BHT), a leading medical technology startup developing innovative non-pharmacological solutions to improve bone health and reduce fractures, today announced that pre-orders are now[…]

Read more

Osteoboost Joins AgeTech Collaborative™ from AARP Accelerator Program

One of the biggest challenges of aging is the loss of bone density, which too often leads to osteoporosis and serious fractures that significantly impact quality of life.  Our mission with Osteoboost is to slow the process of bone loss and preserve bone density and strength, helping people live stronger,[…]

Read more

Osteoboost Wins Big at the 2024 Hitlab Women’s Health Tech Event

Last week I had the honor of presenting Osteoboost, our soon-to-launch FDA-cleared precision vibration therapy medical device, at the 2024 Hitlab Women’s Health Tech event held on October 11. And I’m thrilled to report that Osteoboost won both first place in the seed-stage category and the event’s People’s Choice Award![…]

Read more

In Honor of World Osteoporosis Day – Bone Health is Personal

Almost four years ago, I had my second dexa scan and got the news that I have learned is typical: in the five years after menopause, my bone density went from normal to osteopenia. I lost 13% of my bone density in my spine. I got a weirdly chipper note[…]

Read more

Contact us

Osteoboost is currently available for pre-order. Please sign up below if you would like to be notified when the product is officially launched.

* indicates required